Recherche

Wheelchairs are available for you and your loved ones. You will need a 1 euro coin. You will find wheelchairs at:    Volunteers’ reception, near the information office in the hospital’s main hall Outside the entrance to the Bucopa building  In the Erasmus covered car park  At the Day Hospital  During the week volunteers are available to assist you when moving around the hospital.  Access and organisation of the hospital are designed for people with reduced mobility

The Erasmus Hospital for care that is accessible to all Since 1977 the Erasmus Hospital has been proposing general care adapted to the individual patient. With a capacity of 1,048 beds, every year it is able to treat between 25,000 and 30,000 hospitalised patients and between 350,000 and 400,000 who attend for consultations as outpatients.    Also recognised as a Belgian reference centre for 12 rare diseases and member of several European reference networks, the hospital is situated on the Erasmus hospital and university campus in Anderlecht. The campus is also home to the Jules Bordet Institute, the Faculty of Medicine of the Université Libre de Bruxelles, the Faculty of Motor Sciences and the School of Public Health.    Two internal centres (the Erasmus Medical Centre – EMC and the Erasmus Imedia Centre), an external polyclinic (Lothier) and two external centres (Trauma and Rehabilitation Centre – CTR and the Geriatric Rehabilitation Centre – CRG) complete the patient care.    The Erasmus Hospital within the Brussels University Hospital (H.U.B.) Since 2021 the Erasmus Hospital has been a part of the Brussels University Hospital (H.U.B.), alongside the Jules Bordet Institute and the Queen Fabiola University Children's Hospital. These three renowned institutions have the same ambition to improve intra-hospital cooperation and to guarantee optimal care pathways while retaining their individual identities. Each is recognised nationally and internationally for their high quality care at the leading edge of technology and for their projects and medical innovation, whether in the field of oncology, paediatrics or specialised treatment. By bringing together these individual hospitals within an umbrella structure, the patient is guaranteed a complete care pathway.    The Erasmus Hospital in figures 986 beds Between 25 000 and 30 000 hospitalisations a year Between 350 000 and 400 000 consultations a year Our history Since it was founded in 1977, the Erasmus Hospital has continuously developed its activities with the sole aim of guaranteeing high quality care for patients. As a university hospital, the development of infrastructures on the campus is also a priority.    Discover the history of the Erasmus Hospital :  1977 : Inauguration of the Erasmus Hospital and its first 27 beds   1982 : Creation of the Erasmus Fund for medical research   1989 : Signing of the quality charter with the aim of improving the quality of all the hospital's activities, for patients and staff  1991 : Inauguration of the Faculty of Medicine on the campus  2004 : Inauguration of the new Day Hospital   2007 : Inauguration of the Geriatric Day Hospital     2015 : Inauguration of the Lothier Polyclinic in Brussels city centre    2017 : Inauguration of the Trauma and Rehabilitation Centre (CTR) in Laeken    2021 : Grouping of the Erasmus Hospital alongside the Jules Border Institute and Children's Hospital under the name Brussels University Hospital (H.U.B.)    New Erasmus : This major project will make it possible to welcome new modern hospital services while respecting planning and landscaping requirements

What are interstitial pneumonias? Diffuse interstitial pneumonias are a group of relatively rare lung diseases. They are disorders of the lung parenchyma (that is, of the lung itself) with a varying degree of inflammation and fibrosis resulting in a sometimes severe respiratory insufficiency.  The principal pathologies covered by this term are •    Idiopathic pulmonary fibrosis •    Sarcoidosis •    Non-specific interstitial pneumonia •    Cryptogenic organising pneumonia •    Lung disorders secondary to autoimmune diseases (connective tissue disease and vasculitis)  •    Hypersensitivity pneumonitis (farmer‘s lung, bird fancier’s lung •    Some pneumonias of occupational origin (exposure to asbestos or to mineral or metal dust) or drug induced Idiopathic pulmonary fibrosis (IPF) Idiopathic pulmonary fibrosis (IPF) is the most common disease of this group, together with sarcoidosis. The annual incidence is estimated at 10 new cases for 100,000 persons per year and this figure seems to be rising. In IPF the lung is progressively destroyed and replaced by scar tissue. This results in an irreversible and progressive respiratory insufficiency.  Causes and risk factors Its etiology is unknown but smoking, pollution, exposure to certain viruses and the presence of gastroesophageal reflux are risk factors. There are also family forms in which gene mutations have been clearly identified.  IPF affects more men than women and is generally diagnosed at around the age of 60.  Diagnosis and treatment These diseases are rare and therefore demand particular expertise. The diagnosis is complex and requires a multidisciplinary discussion.  In the case of idiopathic pulmonary fibrosis there are two possible treatments: with Esbriet or Ofev. These do not cure the diseases but do make it possible to slow its progress.  If the patient shows no contraindications a lung transplant must be envisaged. In this particular case we work closely together with the lung transplant team. Multidisciplinary meetings are held regularly to discuss complex cases and we have a clinical research unit that permits access to an advanced research programme in this field and patients are invited to participate in international trials to test new treatments.  The Erasmus Hospital is a member of the European experts network in the field of diffuse interstitial pneumonia (ERN lung). We are active in the field of clinical research by providing the opportunity to participate in research protocols and clinical trials.  Finally, we support and participate actively in activities organised by patients’ associations, in particular the   Association Belge Francophone contre la Fibrose Pulmonaire (ABFFP). Useful documents Informations destinées aux patient(e)s Brochure : thérapie par Esbriet (pirfénidone) Brochure : Fibrose Pulmonaire Idiopathique (FPI) Brochure : traitement de votre Fibrose Pulmonaire Idiopathique (FPI) avec OFEV® Requests for opinion Téléchargez le document de demande d'avis de la part du médecin traitant ou spécialiste à destination de la Clinique des pneumopathies interstitielles diffuses. Demande d'avis Multidisciplinary team Découvrez l'équipe multidisciplinaire de la Clinique de Pneumopathies interstitielles et diffuses. Organisation chart Our specialists

What is intrauterine insemination? Intrauterine insemination (IUI) is a simple assisted reproductive technique that involves placing a prepared sperm sample into the uterine cavity using a thin catheter. The goal of IUI is to facilitate the meeting of gametes (eggs and sperm) within the female reproductive tract. If the sperm used is from the partner, it is called homologous insemination (IAC); if donor sperm is used, it is called donor insemination (IAD).Who is intrauterine insemination intended for?IUI may be recommended in the following cases:Certain abnormalities of the cervix or cervical mucus.Mild or moderate endometriosis.Moderate sperm quality issues, such as reduced sperm count or motility.Erectile or ejaculation disorders of anatomical, neurological, or psychological origin.Idiopathic infertility, meaning no identifiable cause after fertility evaluation.When using donor sperm.Should ovarian stimulation be combined with intrauterine insemination?Ovarian stimulation aims to correct ovulation disorders and/or increase the number of pre-ovulatory follicles containing mature eggs. Stimulation increases the chances of pregnancy, but also the risks of multiple pregnancy and ovarian hyperstimulation. This treatment is available as oral tablets or subcutaneous injections. In the absence of female infertility factors, IUI without ovarian stimulation is preferred. Medical services What tests should you undergo before intrauterine insemination?The assessment includes:Blood tests for both partners.Semen analysis for the male partner.Examination of the uterine cavity and tubal patency using ultrasound or radiography (cf - Fertility Imaging)In practice:IUI should be scheduled on the day of ovulation.Ovulation monitoringDuring the first part of the menstrual cycle, regular blood tests, sometimes combined with transvaginal ultrasounds, confirm follicular maturation and determine the timing of ovulation or the need for ovulation triggering (via subcutaneous injection). In regular cycles, ovulation monitoring can initially be done using urine tests.Sperm preparationOn the day of IUI, a sperm sample is provided by the partner through masturbation, though in some cases, frozen sperm may be thawed. The laboratory prepares the sample to isolate the most fertilizing sperm. This preparation takes about one hour.In IUI-D, thawed donor sperm is used.The insemination procedureAfter placing a speculum and cleaning the cervix, the prepared sperm is injected into the uterine cavity using a thin catheter and syringe. The procedure lasts a few minutes and is generally painless. After about ten minutes of rest, you can resume normal activities.The luteal phaseDuring the first IUI cycle, a blood test is commonly performed one week after insemination to measure progesterone and ensure proper ovulation. If progesterone levels are insufficient and pregnancy has not occurred, progesterone supplementation will be systematically offered in subsequent cycles.Pregnancy testTwelve to fourteen days after insemination, a blood test determines the presence of an early pregnancy. A follow-up is scheduled the following week, followed by an ultrasound to confirm pregnancy progression.In case of failure, and depending on prior discussions with your doctor, you may undergo another IUI cycle or consult your physician to discuss other options. Our specialists Associated servicesGynecology-Obstetrics DepartmentPr. Anne DELBAEREPr. Fabienne DEVREKERDr. Soraya AMIRGHOLAMIDr. Elisabeth ANAGNOSTOUDr. Margherita CONDORELLIDr. Serge DE LATHOUWERDr. Michel DIKETEDr. Isabelle DUPONDDr. Oranite GOLDRATDr. Catherine HOUBADr. Christian KAMTO FOTSODr. Caroline LECOCQDr. Noé MOUTARDDr. David PENING Dr. Asma SASSIDr. Mélodie VANDER BORGHT 

What is irritable bowel syndrome? Irritable bowel syndrome is a chronic digestive disorder that affects the small and large intestine. Common symptoms are stomach pain and bloating associated with changes in the intestinal transit (constipation or diarrhoea). An estimated 10% of Belgians suffer from this disease. The causes are multiple and examinations (blood tests, imaging, endoscopy) do not show any anomaly.  Clinic The Functional Digestive Disorders Clinic at the Erasmus Hospital proposes a digestive comfort consultation in order to evaluate the situation, relieve symptoms and improve the quality of life of patients. Treatment includes changes to diet, dietary consultation, medication and sometimes physiotherapy as part of a multidisciplinary approach.    Research Innovative tratment is regularly proposed in the framework of clinical trials.    Our specialists Associated service